Antibodies for cancer therapy and diagnosis
CA 2361877 A1 · Owner: Ridgway, John B. · Inventors: Ridgway, John B.; Carter, Paul J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present application describes a method for making antibodies which can be used for cancer diagnosis or therapy. The application also discloses a method for identifying an antigen which is differentially expressed on the surface of two or more distinct cell populations. The application additionally describes human antibodies directed against decay accelerating factor (DAF) as well as , therapeutic compositions comprising such antibodies. Moreover the application , disclosed a method of treating lung cancer with antibodies directed against DAF.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 29, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 29, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 1, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.